Rice
protein isolate (RPI) has been reported to reduce the incidence of 7,12-dimethylbenz[a]
anthracene-induced mammary
tumors in rats. To determine the potential role of
phytochemicals associated with the RPI, we studied in vitro antitumor activities of an
ether fraction from RPI using human tumor cell lines, including two human
breast carcinoma cell lines (MDA-MB-453 and MCF-7) and two myeloma cell lines (RPMI-8226 and IM-9). Concentration-dependent antiproliferative effects of the
ether fraction were observed in all cell lines using the standard 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide assay. Fraction-induced apoptosis (P < 0.05) was detected in all cell lines, and this was associated with the induction of proapoptotic
bax protein and cdk inhibitors (p21) and the suppression of cdk4 and
cyclin D1 activity. Liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) with both positive and negative modes was used to analyze the
phytochemicals in the
ether fraction from RPI. Fifty-seven
phytochemicals were identified or characterized by their diagnostic fragmentation patterns and direct comparison with the authentic standards on the basis of electrospray ionization-MS/MS data. The major components bound to RPI were lysoglycerophospholipids,
fatty acids, and
fatty acid 3-[2-(2,3-dihydroxy-propoxycarbonyl)-2-hydroxy-ethoxy]-2-hydroxy-propyl
esters.